DOLBY LABORATORIES, INC. (DLB)

Every figure this model derived for DLB, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-26.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 44,925,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-26
cash 670,046,000 CashAndCashEquivalentsAtCarryingValue 2026-06-26
current assets 1,326,041,000 AssetsCurrent 2026-06-26
current liabilities 416,329,000 LiabilitiesCurrent 2026-06-26
equity 2,583,547,000 StockholdersEquity 2026-06-26
ocf 437,598,000 NetCashProvidedByUsedInOperatingActivities 2026-06-26
revenue 1,354,355,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-26
sbc 129,935,000 ShareBasedCompensation 2026-06-26

The ratios

The figures themselves rather than their scores — what somebody looking up DLB on one particular measure came for.

RatioValue
cash operating margin34.1
current ratio3.46
current ratio reported3.19
deferred revenue growth-6.77
dilution pct0.16
ebit cagr3.99
ebit yoy-15.1
fcf margin28.99
growth cv1.51
operating margin17.65
owner earnings margin19.4
revenue growth0.55
revenue growth per share0.39
roic9.87
rpo growth-12.29
rule of 4018.21
sbc pct revenue9.59

What to be careful about

What this model itself distrusts about DLB's figures. Written by the derivation as it ran, not added afterwards.